xylitol has been researched along with inosine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 7 (87.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deufel, T; Gerbitz, K; Gross, M; Hübner, G; Paetzke, I; Pongratz, D; Reimers, CD; Reiter, S; Zöllner, N | 1 |
Parkin, DW; Schramm, VL | 1 |
Higashino, K; Moriwaki, Y; Suda, M; Takahashi, S; Yamamoto, T | 1 |
Estupiñán, B; Schramm, VL | 1 |
Horenstein, BA; Schramm, VL | 1 |
Higashino, K; Moriwaki, Y | 1 |
Chen, XY; Furneaux, RH; Limberg, G; Parkin, DW; Schramm, VL; Tyler, PC | 1 |
Evans, GB; Furneaux, RH; Miles, RW; Parkin, DW; Schramm, VL; Tyler, PC | 1 |
1 review(s) available for xylitol and inosine
Article | Year |
---|---|
[Pharmacological agents affecting uric acid metabolism].
Topics: Allopurinol; Diuretics; Fructose; Gout; Gout Suppressants; Humans; Inosine; Kidney Diseases; Niacin; Purines; Uric Acid; Xylitol | 1996 |
1 trial(s) available for xylitol and inosine
Article | Year |
---|---|
Xylitol-induced increase in the concentration of oxypurines and its mechanism.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Cytosol; Humans; Hypoxanthine; Hypoxanthines; Infusions, Intravenous; Inosine; Intestine, Small; Lactates; Lactic Acid; Liver; Male; Middle Aged; NAD; Phosphates; Pyrazinamide; Pyruvates; Pyruvic Acid; Saline Solution, Hypertonic; Serum Albumin; Uric Acid; Xanthine; Xanthine Dehydrogenase; Xanthines; Xylitol | 1995 |
6 other study(ies) available for xylitol and inosine
Article | Year |
---|---|
Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.
Topics: Ammonia; AMP Deaminase; Drug Therapy, Combination; Humans; Hypoxanthine; Hypoxanthines; Inosine; Lactates; Lactic Acid; Male; Middle Aged; Muscles; Neuromuscular Diseases; Nucleotide Deaminases; Physical Exertion; Ribose; Xylitol | 1986 |
Binding modes for substrate and a proposed transition-state analogue of protozoan nucleoside hydrolase.
Topics: Animals; Binding Sites; Binding, Competitive; Crithidia fasciculata; Enzyme Inhibitors; Hydrogen-Ion Concentration; Inosine; Kinetics; Molecular Structure; N-Glycosyl Hydrolases; Ribitol; Uridine | 1995 |
Guanosine-inosine-preferring nucleoside N-glycohydrolase from Crithidia fasciculata.
Topics: Animals; Chromatography, Affinity; Chromatography, Ion Exchange; Crithidia fasciculata; Electrophoresis, Polyacrylamide Gel; Glycoside Hydrolases; Guanosine; Hydrogen-Ion Concentration; Inosine; Molecular Weight; N-Glycosyl Hydrolases; Ribitol; Substrate Specificity | 1994 |
Electronic nature of the transition state for nucleoside hydrolase. A blueprint for inhibitor design.
Topics: Animals; Arabinose; Computer-Aided Design; Crithidia fasciculata; Electrochemistry; Enzyme Inhibitors; Imino Furanoses; Inosine; Kinetics; Lactones; N-Glycosyl Hydrolases; Protein Conformation; Ribitol; Ribose; Sugar Alcohols | 1993 |
Isozyme-specific transition state inhibitors for the trypanosomal nucleoside hydrolases.
Topics: Animals; Anti-Infective Agents; Arabinose; Deoxyribose; Drug Design; Enzyme Inhibitors; Imino Furanoses; Inosine; Isoenzymes; Kinetics; N-Glycosyl Hydrolases; Ribitol; Sugar Alcohols; Trypanosoma brucei brucei | 1997 |
Iminoribitol transition state analogue inhibitors of protozoan nucleoside hydrolases.
Topics: Animals; Crithidia fasciculata; Enzyme Inhibitors; Guanosine; Hydrogen Bonding; Inosine; Macromolecular Substances; N-Glycosyl Hydrolases; Protozoan Proteins; Purines; Pyrimidinones; Pyrroles; Ribitol; Ribose; Structure-Activity Relationship; Substrate Specificity | 1999 |